Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition

Albert Liclican(Gilead Sciences (United States)), Joy Y. Feng(Gilead Sciences (United States)), Roman Sakowicz(Gilead Sciences (United States)), Bart Steiner(Gilead Sciences (United States)), Brian E. Schultz(Gilead Sciences (United States)), Gregg Czerwieniec(Gilead Sciences (United States)), Kathleen S. Keegan(Gilead Sciences (United States)), Loredana Serafini(Gilead Sciences (United States)), Weimei Xing(Gilead Sciences (United States)), Ting Wang(Jilin University), Katherine M. Brendza(Gilead Sciences (United States)), Justin D. Lutz(Gilead Sciences (United States)), Adrian S. Ray(Maine Farmland Trust)
Biochimica et Biophysica Acta (BBA) - General Subjects
January 14, 2020
10.1016/j.bbagen.2020.129531
Cited by 93

Related Papers

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
|mBio|2018|1.5k
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
|Cell Reports|2020|541
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway
|Acta Pharmacologica Sinica|2016|182
Emerging agents that target signaling pathways in cancer stem cells
|Journal of Hematology & Oncology|2020|176